<SEC-DOCUMENT>0001641172-25-008359.txt : 20250502
<SEC-HEADER>0001641172-25-008359.hdr.sgml : 20250502
<ACCEPTANCE-DATETIME>20250502162611
ACCESSION NUMBER:		0001641172-25-008359
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250429
FILED AS OF DATE:		20250502
DATE AS OF CHANGE:		20250502

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			SURIA SUKSES ENGINEERING SDN BHD
		CENTRAL INDEX KEY:			0002044793
		ORGANIZATION NAME:           	
		STATE OF INCORPORATION:			N8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50626
		FILM NUMBER:		25908972

	BUSINESS ADDRESS:	
		STREET 1:		L-3-E-8, ENTERPRISE 4
		STREET 2:		TAMAN TEKNOLOGI MRANTI BUKIT JALIL
		CITY:			KUALA LUMPUR
		STATE:			N8
		ZIP:			57000
		BUSINESS PHONE:		6012-2237897

	MAIL ADDRESS:	
		STREET 1:		L-3-E-8, ENTERPRISE 4
		STREET 2:		TAMAN TEKNOLOGI MRANTI BUKIT JALIL
		CITY:			KUALA LUMPUR
		STATE:			N8
		ZIP:			57000

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cyclacel Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001130166
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				911766850
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922
		BUSINESS PHONE:		908-517-7330

	MAIL ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XCYTE THERAPIES INC
		DATE OF NAME CHANGE:	20001218
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2025-04-29</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001130166</issuerCik>
        <issuerName>Cyclacel Pharmaceuticals, Inc.</issuerName>
        <issuerTradingSymbol>CYCC</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0002044793</rptOwnerCik>
            <rptOwnerName>SURIA SUKSES ENGINEERING SDN BHD</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>26-13A STELLAR SUITES, JALAN</rptOwnerStreet1>
            <rptOwnerStreet2>PUTERI 4/7, BANDAR PUTERI</rptOwnerStreet2>
            <rptOwnerCity>PUCHONG SELANGOR,</rptOwnerCity>
            <rptOwnerState>N8</rptOwnerState>
            <rptOwnerZipCode>47100</rptOwnerZipCode>
            <rptOwnerStateDescription>MALAYSIA</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Cyclacel Common Stock, par value $0.0001 per share</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>250000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <remarks>Chen Choon Seng, the authorized representative of Suria Sukses Engineering Sdn. Bhd., has been deputized to represent the Reporting Person on the board of directors of the Issuer.</remarks>

    <ownerSignature>
        <signatureName>/s/ Chen Choon Seng</signatureName>
        <signatureDate>2025-05-02</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
